• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝豆状核变性患者皮下脂肪瘤患病率增加。

Increased Prevalence of Subcutaneous Lipomas in Patients With Wilson Disease.

作者信息

Schaefer Mark, Gotthardt Daniel N, Didion Christian, Stremmel Wolfgang, Weiss Karl H

机构信息

Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany.

出版信息

J Clin Gastroenterol. 2015 Aug;49(7):e61-3. doi: 10.1097/MCG.0000000000000248.

DOI:10.1097/MCG.0000000000000248
PMID:25291347
Abstract

GOALS

To determine the prevalence and characteristics of lipomas in patients with Wilson disease.

BACKGROUND

Wilson disease is an autosomal recessive disorder resulting in copper accumulation in the liver and the central nervous tissue. Subcutaneous lipomas were often noted by the authors during clinical examinations of patients with Wilson disease. This is the first study to analyze the prevalence and progression of lipoma development in patients with Wilson disease.

STUDY

Eighty consecutive patients attending a tertiary care center were examined for the presence of subcutaneous lipomas.

RESULTS

Subcutaneous lipomas could be detected during the examination of 21 (26%) of the 80 patients with Wilson disease. Multiple subcutaneous lipomas were present in 16 (76%) of the 21 affected patients. Lipomas were mainly found on the extremities and the trunk. Neither initial presentation nor decoppering treatment influenced the presence or course of lipomas in these patients.

CONCLUSIONS

Subcutaneous lipoma formation is more common in patients with Wilson disease than in the general population. We suggest that the presence of lipomas contributes to the differential diagnosis of Wilson disease.

摘要

目的

确定威尔逊病患者脂肪瘤的患病率及特征。

背景

威尔逊病是一种常染色体隐性疾病,会导致肝脏和中枢神经组织中铜蓄积。作者在对威尔逊病患者进行临床检查时经常注意到皮下脂肪瘤。这是第一项分析威尔逊病患者脂肪瘤发生的患病率及进展情况的研究。

研究

对一家三级护理中心的80例连续就诊患者进行皮下脂肪瘤检查。

结果

在80例威尔逊病患者中,有21例(26%)在检查时可检测到皮下脂肪瘤。21例受影响患者中有16例(76%)存在多个皮下脂肪瘤。脂肪瘤主要见于四肢和躯干。这些患者的初始表现和驱铜治疗均未影响脂肪瘤的存在或病程。

结论

威尔逊病患者皮下脂肪瘤的形成比普通人群更为常见。我们认为脂肪瘤的存在有助于威尔逊病的鉴别诊断。

相似文献

1
Increased Prevalence of Subcutaneous Lipomas in Patients With Wilson Disease.肝豆状核变性患者皮下脂肪瘤患病率增加。
J Clin Gastroenterol. 2015 Aug;49(7):e61-3. doi: 10.1097/MCG.0000000000000248.
2
Differential diagnosis of benign peripheral lipoma from well-differentiated liposarcoma on MR imaging: is comparison of margins and internal characteristics useful?磁共振成像上良性周围脂肪瘤与高分化脂肪肉瘤的鉴别诊断:边缘及内部特征的比较有用吗?
AJR Am J Roentgenol. 2003 Jun;180(6):1689-94. doi: 10.2214/ajr.180.6.1801689.
3
Size, site and clinical incidence of lipoma. Factors in the differential diagnosis of lipoma and sarcoma.脂肪瘤的大小、部位及临床发病率。脂肪瘤与肉瘤鉴别诊断的相关因素。
Acta Orthop Scand. 1983 Dec;54(6):929-34. doi: 10.3109/17453678308992936.
4
Lipomas after blunt soft tissue trauma: are they real? Analysis of 31 cases.钝性软组织创伤后脂肪瘤:它们是真的吗?31例病例分析。
Br J Dermatol. 2007 Jul;157(1):92-9. doi: 10.1111/j.1365-2133.2007.07970.x. Epub 2007 Jun 6.
5
Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.青霉胺对肝豆状核变性患者肝纤维化和炎症的影响。
Exp Clin Transplant. 2008 Dec;6(4):261-3.
6
Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.有症状的威尔逊病患者长期单纯锌治疗:17例患者的经验
Hepatology. 2009 Nov;50(5):1442-52. doi: 10.1002/hep.23182.
7
Posttraumatic lipoma: fact or fiction?创伤后脂肪瘤:确有其事还是无稽之谈?
Skinmed. 2007 Nov-Dec;6(6):266-70. doi: 10.1111/j.1540-9740.2007.06361.x.
8
Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.长期锌治疗对日本肝豆状核变性患者的疗效、稳定性和铜代谢的影响。
Transl Res. 2010 Dec;156(6):350-7. doi: 10.1016/j.trsl.2010.08.007. Epub 2010 Sep 23.
9
Lipoma with osteocartilaginous metaplasia: case report and literature review.伴有骨软骨化生的脂肪瘤:病例报告及文献综述
Pathologica. 2010 Feb;102(1):28-9.
10
Efficacy and safety of oral chelators in treatment of patients with Wilson disease.口服螯合剂治疗威尔逊病患者的疗效和安全性。
Clin Gastroenterol Hepatol. 2013 Aug;11(8):1028-35.e1-2. doi: 10.1016/j.cgh.2013.03.012. Epub 2013 Mar 28.

引用本文的文献

1
A single-cell transcriptomic atlas of immune cells in Wilson disease identifies copper-specific immune regulation.威尔逊病免疫细胞的单细胞转录组图谱揭示了铜特异性免疫调节。
iScience. 2025 Apr 17;28(5):112450. doi: 10.1016/j.isci.2025.112450. eCollection 2025 May 16.
2
A case of Wilson's disease combined with intracranial lipoma and dysplasia of the corpus callosum with review of the literature.1例威尔逊氏病合并颅内脂肪瘤及胼胝体发育异常并文献复习
BMC Neurol. 2024 Jan 25;24(1):44. doi: 10.1186/s12883-024-03541-2.
3
Lipomas: genetic basis of common skin lesions and their occurrence in rare diseases.
脂肪瘤:常见皮肤病变的遗传基础及其在罕见疾病中的发生情况。
Postepy Dermatol Alergol. 2023 Aug;40(4):481-486. doi: 10.5114/ada.2023.129529. Epub 2023 Jul 15.
4
Clinical manifestations of Wilson disease in organs other than the liver and brain.肝和脑以外器官的威尔逊病临床表现。
Ann Transl Med. 2019 Apr;7(Suppl 2):S62. doi: 10.21037/atm.2019.03.30.
5
Phenotypic Analysis of Clinical Narratives Using Human Phenotype Ontology.使用人类表型本体对临床叙述进行表型分析。
Stud Health Technol Inform. 2017;245:581-585.
6
Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.威尔逊病中的伴随免疫相关事件:对螯合剂治疗监测的意义
J Inherit Metab Dis. 2016 Jan;39(1):125-30. doi: 10.1007/s10545-015-9866-0. Epub 2015 Jun 12.